Genetic profiles in relation to sports: a databased approach
|
|
|
- Janice Thomas
- 9 years ago
- Views:
Transcription
1 Genetic profiles in relation to sports: a databased approach NWO & FAPESP Sports & Healthy Living, Sao Paulo, March Peter Taschner, Professor Genome-based Health [email protected]
2 Generade CoE Genomics in perspective Leiden BioScience Park Red life sciences / Life Science and Health [91] [4] [5] [2] BioMedical Agro/Food/Plant BioMarine Industrieel and the surrounding region Leiden Rotterdam Delft Medical Delta 10 billion revenue Over 300 life sciences companies 3 universities 4 universities of applied sciences 2 science parks Targeted molecular diagnostics, image & image guided therapies, interventions and care, vitality
3 Dutch Sports Research Agenda Themes Value of Sports Performance More people, more active, more often 3
4 Dutch National Research Agenda Sports and healthy living research questions 072: How do we improve health and prevent disease through healthy lifestyle and behavior? 075: How can we improve health through sports, exercise and nutrition and which effects will result from this? 102: How can we develop new drugs and treatments to remain as vital and healthy as possible? 4
5 Current research questions and projects How can we identify talent at an early age? Genetic (DNA) profiles? How can we select the optimal personal training intensity? How to monitor recovery of top athletes, normal and revalidating individuals? From better understanding to improving the processes of training and recovery Gene expression (RNA) profiles? Other profiles? 5
6 Much natural variation between individuals Most variants shared between family members 6
7 Effect size/frequency also applies to sports Most variants: small effects Rare variants: specific for family or individual Variants causing sub-clinical musculoskeletal disease? TA Manolio et al. Nature 461, (2009) doi: /nature
8 DNA profile Sports genes Myostatin-related muscle hypertrophy MSTN: LRG_200t1:c.373+5G>A Genome-wide association studies (GWAS) vs Monogenic studies bron:
9 DNA profile The new heel prick? 1000 US$ bron: DOI: /
10 10
11 Research data life cycle FAIR data: Findable: data uniquely and persistently identifiable. Others should be able to find your data. Accessible: conditions for use clear to machines and humans. Interoperable: machine-readable data, terminologies, vocabularies, or ontologies commonly used in the field; Reusable: compliant with the above, sufficiently well described with metadata and provenance information supporting linking or integration with other data sources, enabling proper citation. 11
12 Efficient information retrieval Where to find genetic variant information? Private Local National International Gene and Disease Databases PC Intranet Internet Spreadsheet FAIR Data - National Databases - General Databases - Ethnic Databases Journals Static Web Pages Drawer Accessibility 12
13 Genetic variant information sources Highly heterogeneous Vast amounts of data Limited data integration or standardization Limited search possibilities across databases Difficult to maintain or submit new data NOT FAIR: Standardization necessary 13
14 Standardization Traits Human Variome Project Recommended systems ICF
15 Variant assessment and classification CCG, Köln March 11, 2014
16 Mark variants by level of curation Heidi Rehm CCG, Köln March 11, 2014
17 Matchmaker Exchange Data sharing: Genome/exome/variants: Who has seen this variant or phenotype? Causative variant identification Variant effect determination Beacons: Advertise variant information 17
18 18
19 The promise of genomics for sports, health Better prediction of personal risk factors You in charge: optimise your lifestyle, nutrition, training to increase your performance and health Star Trek Into Darkness, 2009 Gattaca,
20 Your own genome in your hand Apps and databases: Efficient links to other databases? Annotation by patients without privacy issues? Suitable for DNA bank account? Transfer/provide access to (anonymized) personal data Different levels: health care and research Genome sequence in an Illumina ipad app Foto: Adam Jeffery CNBC 20
21 Genotype known: deep phenotyping needed 21
22 How to increase performance? Congratulations, it s a Ronaldo! Guido de Wert, medical ethicist Maastricht UMC: Research shows that people are not at all obsessed getting perfect children. Medical science enables us to prevent severe suffering. 22
23 Challenges Data management Implementation of innovation by the sports community Multidisciplinary research? More knowledge required: Genetic basis of sports talent (nature): Variants with small effect size Structural variation Variants in regulatory sequences Phenotype vs DNA-profile (genotype) Influence of and adaptation to environmental factors: lifestyle, training, etc (nurture) 23
24 The future: Integrated Personal Omics Profiling Monitoring: - at different levels - longitudinal studies - preferably on location RNA-profiling device? In combination with traditional sports performance data, apps, wearables J Chem Biol 20: (2013) 24
25 Monitoring of training effects using RNA-profiles How to determine the optimal training intensity? Concept: Individuals respond differently to training Training induces stress, changes gene expression Personal RNA-profiles in time (RNA-seq) RNA-profile changes as indicators Execution: Blood samples taken at different time points In rest (No intense activity in last 48 hours) Directly after exercise After hour recovery 25
26 Significant gene expression differences T1: Before exercise T2: After exercise T3: After recovery Repeat measurement after 3-monthly training periods Red: Increased expression Green: Decreased expression PLoS ONE 9: e doi: /journal.pone
27 Collaboration with interesting partners? Human sarcopenia studies UAS HAN & University Maastricht, NL Mouse models for sarcopenia + Accelerator mass spectrometry TNO Metabolic Health Research, Leiden, NL Risk factors: - malnutrition - aging - immobilization - COPD - chemotherapy - others Human intervention + ergometer studies UAS Utrecht & Wageningen University, NL food supplements medical nutrition pharma 27
28 International data sharing projects BRCA challenge ( Globin 2020 ( Aims: Collecting all variants involved in breast cancer and hemoglobinopathies Co-developing infrastructure and capacity in participating countries 28
29 Thanks! Questions? Peter Taschner, Professor Genome-based Health
Genetic diagnostics the gateway to personalized medicine
Micronova 20.11.2012 Genetic diagnostics the gateway to personalized medicine Kristiina Assoc. professor, Director of Genetic Department HUSLAB, Helsinki University Central Hospital The Human Genome Packed
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
University Medical Centres
University Medical Centres in the Netherlands AMC UMC Utrecht University Medical Centres University Medical Centres and the Health System Reform in the Netherlands: a Position Paper In the last ten years
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
A Primer of Genome Science THIRD
A Primer of Genome Science THIRD EDITION GREG GIBSON-SPENCER V. MUSE North Carolina State University Sinauer Associates, Inc. Publishers Sunderland, Massachusetts USA Contents Preface xi 1 Genome Projects:
Genetic Testing: Scientific Background for Policymakers
Genetic Testing: Scientific Background for Policymakers Amanda K. Sarata Specialist in Health Policy December 19, 2011 CRS Report for Congress Prepared for Members and Committees of Congress Congressional
Global Alliance. Ewan Birney Associate Director EMBL-EBI
Global Alliance Ewan Birney Associate Director EMBL-EBI Our world is changing Research to Medical Research English as language Lightweight legal Identical/similar systems Open data Publications Grant-funding
Enhancing Functionality of EHRs for Genomic Research, Including E- Phenotying, Integrating Genomic Data, Transportable CDS, Privacy Threats
Enhancing Functionality of EHRs for Genomic Research, Including E- Phenotying, Integrating Genomic Data, Transportable CDS, Privacy Threats Genomic Medicine 8 meeting Alexa McCray Christopher G Chute Rex
How Can Institutions Foster OMICS Research While Protecting Patients?
IOM Workshop on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials How Can Institutions Foster OMICS Research While Protecting Patients? E. Albert Reece, MD, PhD, MBA Vice
School of Nursing. Presented by Yvette Conley, PhD
Presented by Yvette Conley, PhD What we will cover during this webcast: Briefly discuss the approaches introduced in the paper: Genome Sequencing Genome Wide Association Studies Epigenomics Gene Expression
Genetic Testing: Background and Policy Issues
Cornell University ILR School DigitalCommons@ILR Federal Publications Key Workplace Documents 3-2-2015 Genetic Testing: Background and Policy Issues Amanda K. Sarata Congressional Research Service Follow
Genetic testing. The difference diagnostics can make. The British In Vitro Diagnostics Association
6 Genetic testing The difference diagnostics can make The British In Vitro Diagnostics Association Genetic INTRODUCTION testing The Department of Health published Our Inheritance, Our Future - Realising
The Future of the Electronic Health Record. Gerry Higgins, Ph.D., Johns Hopkins
The Future of the Electronic Health Record Gerry Higgins, Ph.D., Johns Hopkins Topics to be covered Near Term Opportunities: Commercial, Usability, Unification of different applications. OMICS : The patient
Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider
Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider Daniel Masys, M.D. Affiliate Professor Biomedical and Health Informatics University of Washington, Seattle
The National Institute of Genomic Medicine (INMEGEN) was
Genome is...... the complete set of genetic information contained within all of the chromosomes of an organism. It defines the particular phenotype of an individual. What is Genomics? The study of the
European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute
European Genome-phenome Archive database of human data consented for use in biomedical research at the European Bioinformatics Institute Justin Paschall Team Leader Genetic Variation / EGA ! European Genome-phenome
TRANSLATIONAL BIOINFORMATICS 101
TRANSLATIONAL BIOINFORMATICS 101 JESSICA D. TENENBAUM Department of Bioinformatics and Biostatistics, Duke University Durham, NC 27715 USA [email protected] SUBHA MADHAVAN Innovation Center for
HOW WILL BIG DATA AFFECT RADIOLOGY (RESEARCH / ANALYTICS)? Ronald Arenson, MD
HOW WILL BIG DATA AFFECT RADIOLOGY (RESEARCH / ANALYTICS)? Ronald Arenson, MD DEFINITION OF BIG DATA Big data is a broad term for data sets so large or complex that traditional data processing applications
Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases
Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Jeff Gulcher, MD PhD Chief Scientific Officer and co-founder decode
TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298
DIAGNOSTICS BUSINESS ANALYSIS SERIES: TECHNOLOGIES, PRODUCTS & SERVICES for MOLECULAR DIAGNOSTICS, MDx ABA 298 By ADAMS BUSINESS ASSOCIATES MAY 2014. May 2014 ABA 298 1 Technologies, Products & Services
Biomedical Big Data and Precision Medicine
Biomedical Big Data and Precision Medicine Jie Yang Department of Mathematics, Statistics, and Computer Science University of Illinois at Chicago October 8, 2015 1 Explosion of Biomedical Data 2 Types
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE E15
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE DEFINITIONS FOR GENOMIC BIOMARKERS, PHARMACOGENOMICS,
http://www.univcan.ca/programs-services/international-programs/canadianqueen-elizabeth-ii-diamond-jubilee-scholarships/
QUANTITATIVE BIOLOGY AND MEDICAL GENETICS FOR THE WORLD PROGRAM ANNOUNCEMENT The "Quantitative Biology and Medical Genetics for the World" program at McGill is offering a number of prestigious Queen Elizabeth
Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects
Report on the Workshop on Establishing a Central Resource of Data from Genome Sequencing Projects Background and Goals of the Workshop June 5 6, 2012 The use of genome sequencing in human research is growing
Summary of Responses to the Request for Information (RFI): Input on Development of a NIH Data Catalog (NOT-HG-13-011)
Summary of Responses to the Request for Information (RFI): Input on Development of a NIH Data Catalog (NOT-HG-13-011) Key Dates Release Date: June 6, 2013 Response Date: June 25, 2013 Purpose This Request
Integration of Genetic and Familial Data into. Electronic Medical Records and Healthcare Processes
Integration of Genetic and Familial Data into Electronic Medical Records and Healthcare Processes By Thomas Kmiecik and Dale Sanders February 2, 2009 Introduction Although our health is certainly impacted
University of Glasgow - Programme Structure Summary C1G5-5100 MSc Bioinformatics, Polyomics and Systems Biology
University of Glasgow - Programme Structure Summary C1G5-5100 MSc Bioinformatics, Polyomics and Systems Biology Programme Structure - the MSc outcome will require 180 credits total (full-time only) - 60
Integration of genomic data into electronic health records
Integration of genomic data into electronic health records Daniel Masys, MD Affiliate Professor Biomedical & Health Informatics University of Washington, Seattle Major portion of today s lecture is based
#Aim2Innovate. Share session insights and questions socially. Genomics, Precision Medicine and the EHR 6/17/2015
Genomics, Precision Medicine and the EHR Making Genomics part of everyday practice Andrew Ury, M.D. CEO and founder, ActX, Inc. June 17, 2015 DISCLAIMER: The views and opinions expressed in this presentation
Connecting Basic Research and Healthcare Big Data
Elsevier Health Analytics WHS 2015 Big Data in Health Connecting Basic Research and Healthcare Big Data Olaf Lodbrok Managing Director Elsevier Health Analytics [email protected] t +49 89 5383 600
Using the Grid for the interactive workflow management in biomedicine. Andrea Schenone BIOLAB DIST University of Genova
Using the Grid for the interactive workflow management in biomedicine Andrea Schenone BIOLAB DIST University of Genova overview background requirements solution case study results background A multilevel
Data deluge (and it s applications) Gianluigi Zanetti. Data deluge. (and its applications) Gianluigi Zanetti
Data deluge (and its applications) Prologue Data is becoming cheaper and cheaper to produce and store Driving mechanism is parallelism on sensors, storage, computing Data directly produced are complex
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS
BBSRC TECHNOLOGY STRATEGY: TECHNOLOGIES NEEDED BY RESEARCH KNOWLEDGE PROVIDERS 1. The Technology Strategy sets out six areas where technological developments are required to push the frontiers of knowledge
Report of the DTL focus meeting on Life Science Data Repositories
Report of the DTL focus meeting on Life Science Data Repositories Goal The goal of the meeting was to inform and discuss research data repositories for life sciences. The big data era adds to the complexity
NGS and complex genetics
NGS and complex genetics Robert Kraaij Genetic Laboratory Department of Internal Medicine [email protected] Gene Hunting Rotterdam Study and GWAS Next Generation Sequencing Gene Hunting Mendelian gene
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision
Vision for the Cohort and the Precision Medicine Initiative Francis S. Collins, M.D., Ph.D. Director, National Institutes of Health Precision Medicine Initiative: Building a Large U.S. Research Cohort
European registered Clinical Laboratory Geneticist (ErCLG) Core curriculum
(February 2015; updated from paper issued by the European Society of Human Genetics Ad hoc committee for the accreditation of clinical laboratory geneticists, published in February 2012) Speciality Profile
Validation and Replication
Validation and Replication Overview Definitions of validation and replication Difficulties and limitations Working examples from our group and others Why? False positive results still occur. even after
TUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives
1 TUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives The central aim of the School of Medicine is to produce highly competent, intellectually curious and caring physicians. To this
Genomics and the EHR. Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation
Genomics and the EHR Mark Hoffman, Ph.D. Vice President Research Solutions Cerner Corporation Overview EHR from Commercial Perspective What can be done TODAY? What could be done TOMORROW? What are some
Big Data jako součást našeho života. Zdenek Panec: June, 2015
Big Data jako součást našeho života Zdenek Panec: June, 2015 Agenda Big Data talk.. Primary Big Data Scenarios Big Data as Chance & Risk SAP HANA Platform 2013 SAP AG or an SAP affiliate company. All rights
Presenting data: how to convey information most effectively Centre of Research Excellence in Patient Safety 20 Feb 2015
Presenting data: how to convey information most effectively Centre of Research Excellence in Patient Safety 20 Feb 2015 Biomedical Informatics: helping visualization from molecules to population Dr. Guillermo
The M.U.R.D.O.C.K. Study
1 The M.U.R.D.O.C.K. Study Measurement to Understand Reclassification of Disease Of Cabarrus/Kannapolis Jessica Tenenbaum, PhD and many, many others 2 MURDOCK Study Measurement to Understand the Reclassification
AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE
ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS
NETH-ER AND THE EU KNOWLEDGE AND INNOVATION AGENDA TO 2020
POSITION PAPER NETH-ER AND THE EU KNOWLEDGE AND INNOVATION AGENDA TO 2020 CONTINUE TO INVEST IN KNOWLEDGE AND SCIENCE KNOWLEDGE AND INNOVATION ESSENTIAL FOR RENEWED GROWTH IN EUROPE Through constant innovation,
TUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives
TUFTS UNIVERSITY SCHOOL OF MEDICINE Institutional Educational Objectives The central aim of the School of Medicine is to produce highly competent, intellectually curious and caring physicians. To this
Worldwide Collaborations in Molecular Profiling
Worldwide Collaborations in Molecular Profiling Lillian L. Siu, MD Director, Phase I Program and Cancer Genomics Program Princess Margaret Cancer Centre Lillian Siu, MD Contracted Research: Novartis, Pfizer,
Analysis of Illumina Gene Expression Microarray Data
Analysis of Illumina Gene Expression Microarray Data Asta Laiho, Msc. Tech. Bioinformatics research engineer The Finnish DNA Microarray Centre Turku Centre for Biotechnology, Finland The Finnish DNA Microarray
G E N OM I C S S E RV I C ES
GENOMICS SERVICES THE NEW YORK GENOME CENTER NYGC is an independent non-profit implementing advanced genomic research to improve diagnosis and treatment of serious diseases. capabilities. N E X T- G E
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics
Consultation Response Medical profiling and online medicine: the ethics of 'personalised' healthcare in a consumer age Nuffield Council on Bioethics Response by the Genetic Interest Group Question 1: Health
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS
IMPLEMENTING BIG DATA IN TODAY S HEALTH CARE PRAXIS: A CONUNDRUM TO PATIENTS, CAREGIVERS AND OTHER STAKEHOLDERS - WHAT IS THE VALUE AND WHO PAYS 29 OCTOBER 2015 DR. DIRK J. EVERS BACKGROUND TreatmentMAP
Dr Alexander Henzing
Horizon 2020 Health, Demographic Change & Wellbeing EU funding, research and collaboration opportunities for 2016/17 Innovate UK funding opportunities in omics, bridging health and life sciences Dr Alexander
BIOINF 525 Winter 2016 Foundations of Bioinformatics and Systems Biology http://tinyurl.com/bioinf525-w16
Course Director: Dr. Barry Grant (DCM&B, [email protected]) Description: This is a three module course covering (1) Foundations of Bioinformatics, (2) Statistics in Bioinformatics, and (3) Systems
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE
Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE CRUK Stratified Medicine Initiative Somatic mutation testing for prediction of treatment response in patients with solid tumours:
Genevestigator Training
Genevestigator Training Gent, 6 November 2012 Philip Zimmermann, Nebion AG Goals Get to know Genevestigator What Genevestigator is for For who Genevestigator was created How to use Genevestigator for your
2019 Healthcare That Works for All
2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To
Future Directions in Clinical Research. Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center
Future Directions in Clinical Research Karen Kelly, MD Associate Director for Clinical Research UC Davis Cancer Center Outline 1. Status of Cancer Treatment 2. Overview of Clinical Research at UCDCC 3.
escience and Post-Genome Biomedical Research
escience and Post-Genome Biomedical Research Thomas L. Casavant, Adam P. DeLuca Departments of Biomedical Engineering, Electrical Engineering and Ophthalmology Coordinated Laboratory for Computational
2nd MuscleTech Network Workshop. From translational Research to translational Medicine. CONCLUSIONS AND CLOSING REMARKS Dr.
2nd MuscleTech Network Workshop. From translational Research to translational Medicine. CONCLUSIONS AND CLOSING REMARKS Dr. Carles Pedret MUSCLE AND TENDON WORKSHOP HEALTH AND GENERAL POPULATION SPORTS
Core Facility Genomics
Core Facility Genomics versatile genome or transcriptome analyses based on quantifiable highthroughput data ascertainment 1 Topics Collaboration with Harald Binder and Clemens Kreutz Project: Microarray
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger
The Developing Person Through the Life Span 8e by Kathleen Stassen Berger Chapter 3 Heredity and Environment PowerPoint Slides developed by Martin Wolfger and Michael James Ivy Tech Community College-Bloomington
Genetic Testing in Research & Healthcare
We Innovate Healthcare Genetic Testing in Research & Healthcare We Innovate Healthcare Genetic Testing in Research and Healthcare Human genetic testing is a growing science. It is used to study genes
Research Roadmap for the Future. National Grape and Wine Initiative March 2013
Research Roadmap for the Future National Grape and Wine Initiative March 2013 Objective of Today s Meeting Our mission drives the roadmap Our Mission Drive research to maximize productivity, sustainability
Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future
Genomics and Health Data Standards: Lessons from the Past and Present for a Genome-enabled Future Daniel Masys, MD Professor and Chair Department of Biomedical Informatics Professor of Medicine Vanderbilt
Personalized Medicine: Humanity s Ultimate Big Data Challenge. Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences
Personalized Medicine: Humanity s Ultimate Big Data Challenge Rob Fassett, MD Chief Medical Informatics Officer Oracle Health Sciences 2012 Oracle Corporation Proprietary and Confidential 2 3 Humanity
Big Data and CancerLinQ
Big Data and CancerLinQ Peter Paul Yu, MD, FACP, FASCO Immediate-Past President American Society of Clinical Oncology TACOS Phoenix, Arizona November 13, 2015 Disruptive Change in Oncology driving change
Health Informatics for Medical Librarians. Ana D. Cleveland and Donald B. Cleveland. Table of Contents
Health Informatics for Medical Librarians Ana D. Cleveland and Donald B. Cleveland Table of Contents List of Tables List of Sidebars Preface Acknowledgments Part I: Understanding Health Informatics Chapter
The Ethics of Research with Stored Samples and Data
The Ethics of Research with Stored Samples and Data Sara Chandros Hull, Ph.D. Office of the Clinical Director, NHGRI and Department of Bioethics National Institutes of Health Disclaimers/Disclosures No
Epigenetic variation and complex disease risk
Epigenetic variation and complex disease risk Caroline Relton Institute of Human Genetics Newcastle University ALSPAC Research Symposium 2 & 3 March 2009 Missing heritability Even when dozens of genes
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program
Cystic Fibrosis Webquest Sarah Follenweider, The English High School 2009 Summer Research Internship Program Introduction: Cystic fibrosis (CF) is an inherited chronic disease that affects the lungs and
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives
An EVIDENCE-ENHANCED HEALTHCARE ECOSYSTEM for Cancer: I/T perspectives Chalapathy Neti, Ph.D. Associate Director, Healthcare Transformation, Shahram Ebadollahi, Ph.D. Research Staff Memeber IBM Research,
OME : Mobile Cognitive Healthcare for the Consumer. Michael Nova, M.D. Chief Innovation Officer Pathway Genomics
OME : Mobile Cognitive Healthcare for the Consumer Michael Nova, M.D. Chief Innovation Officer Pathway Genomics 90 % OF ALL THE WORLD S DATA WAS CREATED IN THE LAST 2 YEARS BIG DATA AND OMICS IN MEDICINE
20-10-2015. DNA profiles in DUS testing of grasses. A new UPOV model? Lolium perenne (perennial ryegrass) Pilot study (2014)
2--25 DNA profiles in DUS testing of grasses A new UPOV model? Henk Bonthuis Naktuinbouw Aanvragersoverleg Rvp Wageningsche Berg 9 oktober 25 Lolium perenne (perennial ryegrass) Challenges Genetically
The 100,000 genomes project
The 100,000 genomes project Tim Hubbard @timjph Genomics England King s College London, King s Health Partners Wellcome Trust Sanger Institute ClinGen / Decipher Washington DC, 26 th May 2015 The 100,000
Medical Informatics II
Medical Informatics II Zlatko Trajanoski Institute for Genomics and Bioinformatics Graz University of Technology http://genome.tugraz.at [email protected] Medical Informatics II Introduction
Human Genome Organization: An Update. Genome Organization: An Update
Human Genome Organization: An Update Genome Organization: An Update Highlights of Human Genome Project Timetable Proposed in 1990 as 3 billion dollar joint venture between DOE and NIH with 15 year completion
Your Future by Design
Retirement Research Series Your Future by Design Health, money, retirement: The different needs of men and women This research report is one of several reports in the Your Future by Design Retirement Research
Next Generation Sequencing: Technology, Mapping, and Analysis
Next Generation Sequencing: Technology, Mapping, and Analysis Gary Benson Computer Science, Biology, Bioinformatics Boston University [email protected] http://tandem.bu.edu/ The Human Genome Project took
Principles of Sports Nutrition
Principles of Sports Nutrition Student Education Program Course Outline CHI Sports Nutrition Education Program Course Title: Course Hours: Principles of Sports Nutrition (PSN) 24 12 weeks (12 - two hour
Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs
Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials)
ALCHEMIST (Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials) 3 Integrated Trials Testing Targeted Therapy in Early Stage Lung Cancer Part of NCI s Precision Medicine Effort in
Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics
Session # : 46 Day/Time: Friday, May 1, 2015, 1:00 4:00 pm Title: Genetics and Hearing Loss: Clinical and Molecular Characteristics Presenter: Kathleen S. Arnos, PhD, Gallaudet University This presentation
